TP53 and posterior cortical atrophy: To further study the functional impact of TP53 mutations on the SREBP-mediated metabolic pathways, we selected human metastatic PCa cell lines with various TP53 status, such as PC-3 (p53-null) and DU145 (heterozygous p53, P223L and V274F), as cell models.